Reactogenicity of a three-dose pertussis acellular vaccine catch-up in children 21–40 months of age

• 9 April 1999
• journal article
• clinical trial
• Published by Elsevier in Vaccine
• Vol. 17  (15-16) , 2030-2035
• https://doi.org/10.1016/s0264-410x(98)00405-8

Abstract

Keywords

• ACELLULAR PERTUSSIS VACCINES
• CATCH-UP
• SAFETY